A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177–labeled Prostate-specific Membrane Antigen–targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer - European Urology
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer | NEJM
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study | The BMJ
Prostate cancer screening is no longer automatic. That's turned out to be a sensible change.
Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study | British Journal of Cancer
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer | Business Wire
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis | HTML
Prostate‐specific antigen testing rates and referral patterns from general practice data in England - Moss - 2016 - International Journal of Clinical Practice - Wiley Online Library
Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study | British Journal of Cancer
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate | NEJM
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports
Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research
Prostate Cancer Screening Recommendations for General and Specific Populations in the Western Nations - European Medical Journal
Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine - ScienceDirect
Quantitative Analysis of Prostate Specific Antigen Isoforms Using Immunoprecipitation and Stable Isotope Labeling Mass Spectrometry | Analytical Chemistry
The World Journal of Men's Health
Prostate-specific antigen (PSA) test - Patient Information
Fortel® - Prostate (PSA) - Biomerica
Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong - Clinical Genitourinary Cancer
Medical Science Monitor | Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models - Article abstract #929913
September is Prostate Cancer Awareness Month | Cookeville Regional Medical Center
Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study | Scientific Reports
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age - European Urology
The PSA Test For Prostate Cancer: No Before, Now Maybe | KERA News
